🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study was to compare the rate and extent of absorption of a single dos...
Status
Completed
Location
Galderma Investigational Site 7024
Start Date
2022-08-11
Trial ID
NCT05405985
Treatments Being Tested
The primary objective is to demonstrate that the auto-injector(AI) is suita...
Status
Completed
Location
Regeneron Research Facility
Start Date
2019-01-23
Trial ID
NCT03491904
Treatments Being Tested
The objective of this study is to evaluate the bioavailability of risankizu...
Status
Completed
Location
Acpru /Id# 210844
Start Date
2019-04-02
Trial ID
NCT05283681
Treatments Being Tested
This is phase 1 study to Compare the Pharmacokinetics, Safety and Immunogen...
Status
Completed
Location
Korea University Guro Hospital
Start Date
2025-05-30
Trial ID
NCT06951828
This is a phase 3 study to evaluate the usability of the CT-P47 auto-inject...
Status
Unknown
Location
Multiple Locations
Start Date
2023-02-06
Trial ID
NCT05725434
Treatments Being Tested
The purpose of this study is to look at the amount of the study drug, LY307...
Status
Completed
Location
Covance Clinical Research Inc
Start Date
2018-09-06
Trial ID
NCT03662100
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness, safety and tole...
Status
Completed
Location
Dv0013 50628
Start Date
2024-08-27
Trial ID
NCT06471361
Treatments Being Tested
The purpose of the study is to evaluate the pharmakokinetics (PK), safety, ...
Status
Completed
Location
Up0033 002
Start Date
2018-10-15
Trial ID
NCT03707717
Treatments Being Tested
This is phase 1 study to Compare the Pharmacokinetics, Safety and Immunogen...
Status
Completed
Location
Korea University Guro Hospital
Start Date
2026-01-26
Trial ID
NCT07367958
Treatments Being Tested
The primary purpose of this study is to demonstrate pharmacokinetic bioequi...
Status
Completed
Location
Novartis Investigative Site
Start Date
2018-09-11
Trial ID
NCT03560739
Treatments Being Tested